1 |
10-mg dose of e5501-p21% powder |
- |
- |
- |
- |
063 1件: 63 💬 |
2 |
23-valent pneumococcal polysaccharide vaccine |
- |
- |
- |
- |
013 3件: 13, 46, 53 💬 |
3 |
23-valent pneumococcal polysaccharide vaccine (23-ppv) |
- |
- |
- |
- |
013 1件: 13 💬 |
4 |
23-valent polysaccharide pneumococcal vaccine |
- |
- |
- |
- |
096 1件: 96 💬 |
5 |
23-valent polysaccharide pneumococcal vaccine (pneumovax tm) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
6 |
2l polyethylene glycol/ascorbic acid |
Ascorbic acid |
2件: D00018 D00018, D03370 D03370 💬 |
- |
- |
097 1件: 97 💬 |
7 |
5% lidocaine/5 mg/ml 0.02% estradiol compound cream |
Estradiol |
11件: D00105 D00105, D00358 D00358, D01413 D01413, D01617 D01617, D01953 D01953, D02086 D02086, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065, D08127 D08127 💬 |
ESR1 7件: ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 12件: Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway |
226 1件: 226 💬 |
8 |
?-3 polyunsaturated fatty acid |
- |
- |
- |
- |
096 1件: 96 💬 |
9 |
[f-18] fluorodopa positron emission tomography |
- |
- |
- |
- |
006 1件: 6 💬 |
10 |
Advate 1000 iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 1件: 288 💬 |
11 |
Advate 1000iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 1件: 288 💬 |
12 |
Advate 500 iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 1件: 288 💬 |
13 |
Alga dunaliella bardawil powder |
- |
- |
- |
- |
090 1件: 90 💬 |
14 |
Alicalm (polymeric liquid formula) |
- |
- |
- |
- |
096 1件: 96 💬 |
15 |
Alkalinized lidocaine-heparin |
Heparin |
4件: D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 1件: 226 💬 |
16 |
Allogeneic skin-derived abcb5-positive mesenchymal stem cells |
- |
- |
- |
- |
036 1件: 36 💬 |
17 |
American ginseng |
Ginseng |
1件: D06772 D06772 💬 |
- |
- |
013 1件: 13 💬 |
18 |
American ginseng extract ht-1001 |
Ginseng |
1件: D06772 D06772 💬 |
- |
- |
013 1件: 13 💬 |
19 |
Amoxicillin |
Amoxicillin |
3件: D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
006 7件: 6 , 46, 63, 96, 97, 222, 299 💬 |
20 |
Amoxicillin and clavulanic acid |
Amoxicillin |
4件: D00229 D00229, D02925 D02925, D07452 D07452, D07711 D07711 💬 |
- |
- |
299 1件: 299 💬 |
21 |
Amoxicillin and tetracycline |
Amoxicillin |
4件: D00201 D00201, D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
097 1件: 97 💬 |
22 |
Amoxicillin hydrate |
Amoxicillin |
3件: D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
063 1件: 63 💬 |
23 |
Amoxicillin, metronidazole and tetracycline |
Amoxicillin |
7件: D00201 D00201, D00229 D00229, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
097 1件: 97 💬 |
24 |
Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed |
Apomorphine |
2件: D02004 D02004, D07460 D07460 💬 |
DRD1 2件: DRD1, DRD2 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
25 |
Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed |
Apomorphine |
2件: D02004 D02004, D07460 D07460 💬 |
DRD1 2件: DRD1, DRD2 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
26 |
Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed |
Apomorphine |
2件: D02004 D02004, D07460 D07460 💬 |
DRD1 2件: DRD1, DRD2 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
27 |
Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed |
Apomorphine |
2件: D02004 D02004, D07460 D07460 💬 |
DRD1 2件: DRD1, DRD2 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
28 |
Apomorphine nasal powder |
Apomorphine |
2件: D02004 D02004, D07460 D07460 💬 |
DRD1 2件: DRD1, DRD2 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
29 |
Autologous ovalbumin-specific type 1 regulatory t lymphocytes expanded population |
- |
- |
- |
- |
096 1件: 96 💬 |
30 |
Autologous vitd3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (toldc-vitd3) |
- |
- |
- |
- |
013 1件: 13 💬 |
31 |
Avian polyclonal igy antibody against pa |
- |
- |
- |
- |
299 1件: 299 💬 |
32 |
Behavioral: flexibility and postural exercise |
- |
- |
- |
- |
299 1件: 299 💬 |
33 |
Behavioral: posture training |
- |
- |
- |
- |
046 1件: 46 💬 |
34 |
Benlysta - 120 mg - polvere per concentrato per soluzione per infusione - uso endovenoso - flaconcino (vetro) 120 mg 1 flaconcino |
- |
- |
- |
- |
053 1件: 53 💬 |
35 |
Benlysta 400 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
043 2件: 43, 49 💬 |
36 |
Benlysta 400 mg powder for concentrate for solution for infusions |
- |
- |
- |
- |
049 1件: 49 💬 |
37 |
Benlysta 400mg polvere per concentrato per soluzione per infusione |
- |
- |
- |
- |
043 1件: 43 💬 |
38 |
Berberine |
Berberine |
1件: D00092 D00092 💬 |
- |
- |
097 1件: 97 💬 |
39 |
Berberine chloride |
Berberine |
1件: D00092 D00092 💬 |
- |
- |
097 1件: 97 💬 |
40 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection |
- |
- |
- |
- |
013 1件: 13 💬 |
41 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection. |
- |
- |
- |
- |
013 1件: 13 💬 |
42 |
Bladder instillation with heparin/ lidocaine |
Heparin |
4件: D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 1件: 226 💬 |
43 |
Brimonidine tartrate posterior segment drug delivery system (brimo ps dds) applicator system |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
44 |
Bydureon 2 mg powder and solvent for prolonged-release suspension |
- |
- |
- |
- |
006 1件: 6 💬 |
45 |
C-type natriuretic peptide conjugated to multi-arm polyethylene glycol carrier through a cleavable linker |
Polyethylene glycol |
1件: D03370 D03370 💬 |
- |
- |
276 1件: 276 💬 |
46 |
Calcium lactate |
Calcium |
2件: D00936 D00936, D02254 D02254 💬 |
- |
- |
235 1件: 235 💬 |
47 |
Cayston aztreonam 75 mg powder and solvent for nebuliser solution |
Aztreonam |
2件: D00240 D00240, D06558 D06558 💬 |
- |
- |
299 1件: 299 💬 |
48 |
Ceftazidim fresenius kabi 2000 mg poeder voor oplossing voor injectie of infusie |
Ceftazidime |
2件: D00921 D00921, D07654 D07654 💬 |
- |
- |
299 1件: 299 💬 |
49 |
Ceftazidime and tobramycin |
Ceftazidime |
4件: D00063 D00063, D00921 D00921, D02542 D02542, D07654 D07654 💬 |
- |
- |
299 1件: 299 💬 |
50 |
Ceramic on polyethylene articulation |
- |
- |
- |
- |
046 1件: 46 💬 |
51 |
Cftr potentiator |
- |
- |
- |
- |
299 1件: 299 💬 |
52 |
Ciprofloxacin (bayq3939) dry powder for inhalation |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
53 |
Clartihromycin, amoxicillin, and omeprazole |
Amoxicillin |
7件: D00229 D00229, D00455 D00455, D01207 D01207, D02925 D02925, D05259 D05259, D05261 D05261, D07452 D07452 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 1件: 6 💬 |
54 |
Cohort 1: 1.0 x 10^8 polytregs |
- |
- |
- |
- |
035 1件: 35 💬 |
55 |
Cohort 2: 2.5x10^8 polytregs |
- |
- |
- |
- |
035 1件: 35 💬 |
56 |
Colimicina - 1000000 u/4 ml polvere e solvente per soluzione iniettabile per uso intramuscolare1 flaconcino polvere + 1 fiala solvente 4 ml |
- |
- |
- |
- |
299 1件: 299 💬 |
57 |
Combination product: device: axially oscillating sphere dry powder inhaler (aos dpi) |
- |
- |
- |
- |
086 1件: 86 💬 |
58 |
Comparator: diclofenac |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
59 |
Comparator: diclofenac sodium |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
60 |
Cyclophosphamide post transplant |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
065 1件: 65 💬 |
61 |
Cyclosporine a dry powder inhalation (drug) |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
228 1件: 228 💬 |
62 |
Device: four-point cane (fpc) |
- |
- |
- |
- |
013 1件: 13 💬 |
63 |
Device: generic dry powder inhaler |
- |
- |
- |
- |
086 1件: 86 💬 |
64 |
Device: metal on polyethylene articulation |
- |
- |
- |
- |
046 1件: 46 💬 |
65 |
Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
299 1件: 299 💬 |
66 |
Device: poly-l-lactic acid |
L-Lactic acid |
1件: D00111 D00111 💬 |
- |
- |
265 1件: 265 💬 |
67 |
Device: positive expiratory pressure |
- |
- |
- |
- |
299 1件: 299 💬 |
68 |
Device: powerlung trainer |
- |
- |
- |
- |
002 1件: 2 💬 |
69 |
Device: scorpio nrg posterior stabilized (ps) |
- |
- |
- |
- |
046 1件: 46 💬 |
70 |
Device: serial night time position splint |
- |
- |
- |
- |
051 1件: 51 💬 |
71 |
Device: single-point cane (spc) |
- |
- |
- |
- |
013 1件: 13 💬 |
72 |
Device: tobi podhaler |
- |
- |
- |
- |
299 1件: 299 💬 |
73 |
Device: trekking pole (tp). |
- |
- |
- |
- |
013 1件: 13 💬 |
74 |
Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland). |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
235 1件: 235 💬 |
75 |
Dextromethorphan |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
76 |
Dextromethorphan 30 mg |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
096 2件: 96, 97 💬 |
77 |
Dextromethorphan and caffeine |
Caffeine |
5件: D00528 D00528, D00848 D00848, D01453 D01453, D03742 D03742, D03744 D03744 💬 |
ADORA1 17件: ADORA1, ADORA2A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, SIGMAR1 💬 |
Alcoholism 37件: Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Huntington disease, Insulin signaling pathway, Long-term potentiation, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
078 1件: 78 💬 |
78 |
Dextromethorphan hbr and quinidine sulfate |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 1件: 2 💬 |
79 |
Dextromethorphan hydrobromide |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 2件: 13, 46 💬 |
80 |
Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 2件: 2 , 13 💬 |
81 |
Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 2件: 2 , 13 💬 |
82 |
Dextromethorphan/quinidine |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
83 |
Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg) |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
008 1件: 8 💬 |
84 |
Diagnostic test: endogenous thrombin potential |
Thrombin |
1件: D00090 D00090 💬 |
- |
- |
086 2件: 86, 88 💬 |
85 |
Diagnostic test: positive and negative affect scale (panas) |
- |
- |
- |
- |
006 1件: 6 💬 |
86 |
Diagnostic test: postoperative laboratory blood tests at 24 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
87 |
Diagnostic test: postoperative laboratory blood tests at 6 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
88 |
Diagnostic test: postoperative laboratory drainage fluid tests at 24 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
89 |
Diclofenac |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 4件: 13, 34, 46, 271 💬 |
90 |
Diclofenac + omeprazole |
Diclofenac |
7件: D00455 D00455, D00903 D00903, D00904 D00904, D01207 D01207, D05259 D05259, D05261 D05261, D07816 D07816 💬 |
ATP4A 4件: ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease 26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
91 |
Diclofenac 50 milligrams |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
271 1件: 271 💬 |
92 |
Diclofenac sodium |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
034 2件: 34, 46 💬 |
93 |
Diclofenac sodium topical gel |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
94 |
Diclofenac sr |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
271 1件: 271 💬 |
95 |
Dimebon + dextromethorphan |
Dextromethorphan |
4件: D00848 D00848, D03742 D03742, D03744 D03744, D09917 D09917 💬 |
ACHE 7件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
96 |
Diosminex, 500 mg, tabletki powlekane |
- |
- |
- |
- |
265 1件: 265 💬 |
97 |
Dry powder tobramycin |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
98 |
Egg albumen powder |
Egg |
- |
- |
- |
096 1件: 96 💬 |
99 |
Enbrel 25 mg powder and solvent for solution for injection |
- |
- |
- |
- |
046 1件: 46 💬 |
100 |
Enbrel 50 mg powder and solvent for solution for injection |
- |
- |
- |
- |
046 1件: 46 💬 |
101 |
Esomeprazole |
Esomeprazole |
4件: D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 6件: 13, 46, 86, 98, 298, 299 💬 |
102 |
Esomeprazole 20 mg |
Esomeprazole |
4件: D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
046 1件: 46 💬 |
103 |
Ezogabine |
Ezogabine |
1件: D09569 D09569 💬 |
KCNQ1 5件: KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 |
Adrenergic signaling in cardiomyocytes 6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection |
002 2件: 2 , 144 💬 |
104 |
Ezogabine (us only) |
Ezogabine |
1件: D09569 D09569 💬 |
KCNQ1 5件: KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 |
Adrenergic signaling in cardiomyocytes 6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection |
144 1件: 144 💬 |
105 |
Ezogabine/retigabine |
Ezogabine |
1件: D09569 D09569 💬 |
KCNQ1 5件: KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 |
Adrenergic signaling in cardiomyocytes 6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection |
144 1件: 144 💬 |
106 |
Fabrazyme - 35 mg polvere per concentrato per soluzione per infusione endovenosa 1 flaconcino |
- |
- |
- |
- |
019 1件: 19 💬 |
107 |
Fenfluramine |
Fenfluramine |
1件: D07945 D07945 💬 |
HTR2A 4件: HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
140 3件: 140, 144, 145 💬 |
108 |
Fenfluramine hcl, dl-fenfluramine, (±)-fenfluramine |
Fenfluramine |
1件: D07945 D07945 💬 |
HTR2A 4件: HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
144 1件: 144 💬 |
109 |
Fenfluramine hydrochloride |
Fenfluramine |
1件: D07945 D07945 💬 |
HTR2A 4件: HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
140 2件: 140, 144 💬 |
110 |
Fenfluramine hydrochloride (colorless) |
Fenfluramine |
1件: D07945 D07945 💬 |
HTR2A 4件: HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
140 2件: 140, 144 💬 |
111 |
Fenfluramine hydrochloride (red) |
Fenfluramine |
1件: D07945 D07945 💬 |
HTR2A 4件: HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
140 1件: 140 💬 |
112 |
Fetal porcine cells, neurocell-pd |
- |
- |
- |
- |
006 1件: 6 💬 |
113 |
Finely ground flaxseed powder |
- |
- |
- |
- |
299 1件: 299 💬 |
114 |
Flucloxacillin 250mg/5ml sugar-free powder for oral solution |
Flucloxacillin |
3件: D01249 D01249, D04196 D04196, D07965 D07965 💬 |
- |
- |
299 1件: 299 💬 |
115 |
Fluticasone propionate, 800 mcg twice daily (post 4fed failure) |
Fluticasone |
2件: D01708 D01708, D07981 D07981 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
116 |
Forlax 4 g, poudre pour solution buvable en sachet |
- |
- |
- |
- |
299 1件: 299 💬 |
117 |
Freeze-dried black raspberry powder |
Raspberry |
- |
- |
- |
097 1件: 97 💬 |
118 |
Genetic: polymerase chain reaction |
- |
- |
- |
- |
028 2件: 28, 60 💬 |
119 |
Genetic: polymorphism analysis |
- |
- |
- |
- |
049 2件: 49, 60 💬 |
120 |
Genotonorm kabipen 5.3 mg polvo y disolvente para sol. inyectable (marca internacional genotropin) |
- |
- |
- |
- |
078 1件: 78 💬 |
121 |
Genotonorm kabipen 5.3 mg polvo y disolvente para solución inyectable (marca internacional genotropin) |
- |
- |
- |
- |
078 1件: 78 💬 |
122 |
Genotropin 12 mg powder and solvent for solution for injection. |
- |
- |
- |
- |
078 1件: 78 💬 |
123 |
Ginger |
Ginger |
1件: D06744 D06744 💬 |
- |
- |
046 1件: 46 💬 |
124 |
Ginseng |
Ginseng |
1件: D06772 D06772 💬 |
- |
- |
013 3件: 13, 46, 53 💬 |
125 |
Green tea polyphenols (egcg/ecg) |
Epigallocatechin gallate |
1件: D06903 D06903 💬 |
- |
- |
006 1件: 6 💬 |
126 |
Haploidentical hsct using tbi free regimen, ''atg'' with ''post transplant cyclophosphamide'' |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
060 1件: 60 💬 |
127 |
Heparin & alkalinized lidocaine bladder instillation |
Heparin |
4件: D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 1件: 226 💬 |
128 |
Heparin 25mg inhalation powder, hard capsule |
Heparin |
1件: D07510 D07510 💬 |
SERPINC1 1件: SERPINC1 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
299 1件: 299 💬 |
129 |
Histamine |
Histamine |
1件: D08040 D08040 💬 |
HRH1 4件: HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
130 |
Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh |
- |
- |
- |
- |
036 1件: 36 💬 |
131 |
Hydroxychloroquine |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
013 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
132 |
Hydroxychloroquine (z0188) |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
049 1件: 49 💬 |
133 |
Hydroxychloroquine + prednisone |
Hydroxychloroquine |
2件: D00473 D00473, D08050 D08050 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
084 1件: 84 💬 |
134 |
Hydroxychloroquine high |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
049 1件: 49 💬 |
135 |
Hydroxychloroquine higher dose |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
090 1件: 90 💬 |
136 |
Hydroxychloroquine lower dose |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
090 1件: 90 💬 |
137 |
Hydroxychloroquine or chloroquine |
Chloroquine |
4件: D02125 D02125, D02366 D02366, D03469 D03469, D08050 D08050 💬 |
- |
- |
049 1件: 49 💬 |
138 |
Hydroxychloroquine reduced |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
049 1件: 49 💬 |
139 |
Hydroxychloroquine sulfate |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
046 2件: 46, 66 💬 |
140 |
Hydroxychloroquine sulphate |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
096 1件: 96 💬 |
141 |
Idpm: inhaled dry powder mannitol |
Mannitol |
1件: D00062 D00062 💬 |
- |
- |
299 1件: 299 💬 |
142 |
Iduronate-2-sulfatase fused to a fc polypeptide that binds to the human transferrin receptor |
- |
- |
- |
- |
019 1件: 19 💬 |
143 |
Immediate post operative bioassay of parathyroid hormone |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
144 |
Inflectra 100 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
145 |
Inhaled dry powder mannitol |
Mannitol |
1件: D00062 D00062 💬 |
- |
- |
299 1件: 299 💬 |
146 |
Inhaled dry powder treprostinil (liq861) |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 1件: 86 💬 |
147 |
Inhaled tobramycin |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
148 |
Iv tobramycin |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
149 |
Jinarc - 15 mg +45 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28x15 mg + 28 x 45 mg) |
- |
- |
- |
- |
067 1件: 67 💬 |
150 |
Jinarc - 30 mg + 60 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 60 mg) |
- |
- |
- |
- |
067 1件: 67 💬 |
151 |
Jinarc - 30 mg +90 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 90 mg) |
- |
- |
- |
- |
067 1件: 67 💬 |
152 |
Korean red ginseng |
Ginseng |
1件: D06772 D06772 💬 |
- |
- |
053 1件: 53 💬 |
153 |
Lansoprazole, amoxicillin, clarithromycin |
Amoxicillin |
5件: D00229 D00229, D00276 D00276, D00355 D00355, D02925 D02925, D07452 D07452 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
222 1件: 222 💬 |
154 |
Leflunomide-sulfasalazine-hydroxychloroquine |
Hydroxychloroquine |
3件: D00448 D00448, D00749 D00749, D08050 D08050 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
046 1件: 46 💬 |
155 |
Lenabasum 20 mg powder in capsule |
- |
- |
- |
- |
051 1件: 51 💬 |
156 |
Lenabasum 5 mg powder in capsule |
- |
- |
- |
- |
051 1件: 51 💬 |
157 |
Levodopa powder for inhalation |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
158 |
Licorice |
Licorice |
1件: D04365 D04365 💬 |
- |
- |
053 1件: 53 💬 |
159 |
Lidocaine |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 10件: 6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬 |
160 |
Lidocaine 1% injectable solution |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
034 1件: 34 💬 |
161 |
Lidocaine 2% without vessel constrictor |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 1件: 51 💬 |
162 |
Lidocaine injection 2% |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
168 1件: 168 💬 |
163 |
Lidocaine patch 5% |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 1件: 13 💬 |
164 |
Lidocaine releasing intravesical system - liris® |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
226 1件: 226 💬 |
165 |
Liposomed polyphenols resveratrol and curcumin |
Curcumin |
- |
- |
- |
002 1件: 2 💬 |
166 |
Liprotamase powder for oral solution |
- |
- |
- |
- |
299 1件: 299 💬 |
167 |
Lisinopril, losartan, and atorvastatin |
Atorvastatin |
7件: D00258 D00258, D00357 D00357, D00362 D00362, D00887 D00887, D07474 D07474, D08131 D08131, D08146 D08146 💬 |
ACE 3件: ACE, AGTR1, HMGCR 💬 |
AGE-RAGE signaling pathway in diabetic complications 22件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 1件: 222 💬 |
168 |
Local anesthesia (lidocaine hydrochloride) |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 1件: 6 💬 |
169 |
Losartan |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
170 |
Losartan and atenolol or propranolol |
Atenolol |
5件: D00235 D00235, D00357 D00357, D00483 D00483, D08146 D08146, D08443 D08443 💬 |
ADRB1 4件: ADRB1, ADRB2, ADRB3, AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 22件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
167 1件: 167 💬 |
171 |
Losartan and nebivolol |
Losartan |
3件: D00357 D00357, D05127 D05127, D08146 D08146 💬 |
ADRB1 2件: ADRB1, AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 21件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
167 1件: 167 💬 |
172 |
Losartan and other angiotensin receptor blockers |
Angiotensin II |
4件: D00150 D00150, D00357 D00357, D02014 D02014, D08146 D08146 💬 |
AGTR1 2件: AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
019 1件: 19 💬 |
173 |
Losartan bluefish 50 mg |
Bluefish |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 1件: 58 💬 |
174 |
Losartan hexal |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
036 1件: 36 💬 |
175 |
Losartan potasico |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
179 1件: 179 💬 |
176 |
Losartan potassium |
Losartan |
3件: D00357 D00357, D08146 D08146, D08403 D08403 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
036 5件: 36, 98, 167, 179, 215 💬 |
177 |
Losartan tablets & qingremoshen granule |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 1件: 222 💬 |
178 |
Lym-x-sorb powder |
- |
- |
- |
- |
299 1件: 299 💬 |
179 |
Lyophilized etanercept powder(yisaipu) |
Etanercept |
1件: D00742 D00742 💬 |
LTA 2件: LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
271 1件: 271 💬 |
180 |
Mango polyphenolics |
Mango |
- |
- |
- |
096 2件: 96, 97 💬 |
181 |
Mannitol inhalation powder |
Mannitol |
1件: D00062 D00062 💬 |
- |
- |
299 1件: 299 💬 |
182 |
Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent) |
- |
- |
- |
- |
013 1件: 13 💬 |
183 |
Meropenem fresenius kabi 1 g poeder voor oplossing voor injectie of infusie |
Meropenem |
2件: D02222 D02222, D08185 D08185 💬 |
- |
- |
299 1件: 299 💬 |
184 |
Methotrexate + salazopyrine + hydroxychloroquine administration |
Hydroxychloroquine |
3件: D00142 D00142, D02115 D02115, D08050 D08050 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
185 |
Methotrexate-sulfasalazine-hydroxychloroquine |
Hydroxychloroquine |
4件: D00142 D00142, D00448 D00448, D02115 D02115, D08050 D08050 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
186 |
Methylprednisolone po |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
187 |
Micellar paclitaxel for injection |
Paclitaxel |
2件: D00491 D00491, D05333 D05333 💬 |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
046 1件: 46 💬 |
188 |
Mogamulizumab |
Mogamulizumab |
1件: D09761 D09761 💬 |
CCR4 1件: CCR4 💬 |
Chemokine signaling pathway 5件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Kaposi sarcoma-associated herpesvirus infection, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor |
026 1件: 26 💬 |
189 |
Multigrain powder (s) |
- |
- |
- |
- |
046 1件: 46 💬 |
190 |
Myelostim 34 milions ui/ml - powder and solvent for solution for injection/infusion |
- |
- |
- |
- |
065 1件: 65 💬 |
191 |
Myelostim 34 milions ui/ml, powder and solvent for solution for injection or infusion |
- |
- |
- |
- |
065 1件: 65 💬 |
192 |
Myozyme 50 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
256 1件: 256 💬 |
193 |
Nebcin (tobramycin) |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
194 |
Nebulization tobramycin |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
195 |
Nexium (esomeprazole magnesium) |
Esomeprazole |
4件: D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
298 1件: 298 💬 |
196 |
Nicotine |
Nicotine |
3件: D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 2件: 6 , 84 💬 |
197 |
Nicotine gum |
Nicotine |
3件: D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 1件: 6 💬 |
198 |
Nicotine nasal spray 10 mg/ml (0.5 mg/spray) |
Nicotine |
3件: D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 1件: 6 💬 |
199 |
Nicotine patch |
Nicotine |
3件: D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 2件: 6 , 84 💬 |
200 |
Nicotine transdermal patch |
Nicotine |
3件: D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 1件: 6 💬 |
201 |
Nplate 500 microgramos polvo para solución inyectable |
- |
- |
- |
- |
063 1件: 63 💬 |
202 |
Nucala 100 mg powder for solution for injection |
- |
- |
- |
- |
044 2件: 44, 45 💬 |
203 |
Octanate 100 ui/ml, poudre et solvant pour solution injectable |
Beroctocog alfa |
- |
- |
- |
288 1件: 288 💬 |
204 |
Octanate 50 ui/ml, poudre et solvant pour solution injectable |
Beroctocog alfa |
- |
- |
- |
288 1件: 288 💬 |
205 |
Oligog dry powder for inhalation |
- |
- |
- |
- |
299 1件: 299 💬 |
206 |
Open label rad001 (only used for post-extension phase) |
- |
- |
- |
- |
158 1件: 158 💬 |
207 |
Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone |
Mesalazine |
7件: D00377 D00377, D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
208 |
Orencia 250 mg polvo para concentrado para sol. para perfusión |
- |
- |
- |
- |
046 1件: 46 💬 |
209 |
Orencia 250mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
046 1件: 46 💬 |
210 |
Other: 100% pomegranate juice |
Pomegranate |
- |
- |
- |
096 2件: 96, 97 💬 |
211 |
Other: 4 food elimination diet (post 1fed failure) |
- |
- |
- |
- |
098 1件: 98 💬 |
212 |
Other: event-related evoked potential using electroencephalography (eeg). |
- |
- |
- |
- |
006 1件: 6 💬 |
213 |
Other: general population |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
214 |
Other: glucose -potentiated arginine (gpa) stimulation tests |
Arginine |
1件: D02982 D02982 💬 |
- |
- |
299 1件: 299 💬 |
215 |
Other: histamine |
Histamine |
1件: D08040 D08040 💬 |
HRH1 4件: HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
216 |
Other: hydroxychloroquine/chloroquine |
Chloroquine |
4件: D02125 D02125, D02366 D02366, D03469 D03469, D08050 D08050 💬 |
- |
- |
046 1件: 46 💬 |
217 |
Other: impact of biotherapy on postoperative morbidity in ulcerative colitis |
- |
- |
- |
- |
097 1件: 97 💬 |
218 |
Other: losartan |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
219 |
Other: position sense |
- |
- |
- |
- |
013 1件: 13 💬 |
220 |
Other: postoperative nausea and vomiting at 24 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
221 |
Other: postoperative nausea and vomiting at 6 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
222 |
Other: postoperative pain at 24 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
223 |
Other: postoperative pain at 6 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
224 |
Other: postoperative sore throat and hoarseness at 24 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
225 |
Other: postoperative sore throat and hoarseness at 6 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
226 |
Other: potable water |
Water |
1件: D00001 D00001 💬 |
- |
- |
019 1件: 19 💬 |
227 |
Other: reaction time and postural control |
- |
- |
- |
- |
299 1件: 299 💬 |
228 |
Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry. |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
149 1件: 149 💬 |
229 |
Other: sulfur pool & medicinal mud |
- |
- |
- |
- |
046 1件: 46 💬 |
230 |
Other: tobramycin time of administration |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
231 |
Other: trunk position sense |
- |
- |
- |
- |
013 1件: 13 💬 |
232 |
Other: use of a postpartum diary and additional blood draws |
- |
- |
- |
- |
288 1件: 288 💬 |
233 |
Other: use of a postpartum diary and additional blood draws. |
- |
- |
- |
- |
288 1件: 288 💬 |
234 |
Ovastat 1000 mg, powder for solution for infusion |
Treosulfan |
1件: D07253 D07253 💬 |
- |
- |
065 1件: 65 💬 |
235 |
Ovastat 5000 mg, powder for solution for infusion |
Treosulfan |
1件: D07253 D07253 💬 |
- |
- |
065 1件: 65 💬 |
236 |
Paclitaxel |
Paclitaxel |
2件: D00491 D00491, D05333 D05333 💬 |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
046 2件: 46, 85 💬 |
237 |
Pancreas powder |
- |
- |
- |
- |
299 1件: 299 💬 |
238 |
Pancreatin (pancreas powder) |
Pancrelipase |
1件: D05349 D05349 💬 |
- |
- |
299 1件: 299 💬 |
239 |
Pancreatina (páncreas polvo |
- |
- |
- |
- |
299 1件: 299 💬 |
240 |
Pancreatina (páncreas polvo) |
- |
- |
- |
- |
299 1件: 299 💬 |
241 |
Pancrelipase/pancreas powder |
Pancrelipase |
1件: D05349 D05349 💬 |
- |
- |
298 2件: 298, 299 💬 |
242 |
Pegylated polypeptide hormone of human recombinant origin peg-hgh |
- |
- |
- |
- |
078 1件: 78 💬 |
243 |
Pemirolast |
Pemirolast |
2件: D01088 D01088, D07476 D07476 💬 |
- |
- |
113 1件: 113 💬 |
244 |
Pentosan polysulfat sp 54® injection solution |
- |
- |
- |
- |
019 1件: 19 💬 |
245 |
Pentosan polysulfate |
Pentosan polysulfate |
1件: D05428 D05428 💬 |
- |
- |
019 3件: 19, 26, 226 💬 |
246 |
Pentosan polysulfate sodium |
Pentosan polysulfate |
1件: D05428 D05428 💬 |
- |
- |
019 1件: 19 💬 |
247 |
Pentosan polysulfate sodium 100 mg |
Pentosan polysulfate |
1件: D05428 D05428 💬 |
- |
- |
226 1件: 226 💬 |
248 |
Pentosan polysulphate sp54 |
- |
- |
- |
- |
019 1件: 19 💬 |
249 |
Pentosan polysulphate sp54® |
- |
- |
- |
- |
019 1件: 19 💬 |
250 |
Piperacilline/tazobactam fresenius kabi 2 g/0,25 g poeder voor oplossing voor infusie |
Tazobactam |
1件: D00660 D00660 💬 |
- |
- |
299 1件: 299 💬 |
251 |
Piperacilline/tazobactam fresenius kabi 4 g/0,5 g poeder voor oplossing voor infusie |
Tazobactam |
1件: D00660 D00660 💬 |
- |
- |
299 1件: 299 💬 |
252 |
Plaquenil - hydroxychloroquine 200mg film coated tablets |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
043 3件: 43, 44, 45 💬 |
253 |
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate |
Aluminium |
- |
- |
- |
046 1件: 46 💬 |
254 |
Pneumococcal polysaccharide serotype 1, 2, 3, 4, 5, 6b, 7f, 8, 9n, 9v, 10a, 11a, 12f, 14, 15b, 17f, 18c, 19a, 19f, 20, 22f, 23f and 33f |
- |
- |
- |
- |
046 1件: 46 💬 |
255 |
Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6a, 6b, 7f, 9v, 14, 18c, 19a, 19f and 23f |
- |
- |
- |
- |
046 1件: 46 💬 |
256 |
Pneumococcal polysaccharide vaccine |
- |
- |
- |
- |
046 1件: 46 💬 |
257 |
Pneumococcal polysaccharide vaccine (23 valent) |
- |
- |
- |
- |
046 1件: 46 💬 |
258 |
Pneumococcal polysaccharide vaccine 23 valent |
- |
- |
- |
- |
265 1件: 265 💬 |
259 |
Po |
- |
- |
- |
- |
013 1件: 13 💬 |
260 |
Po azithromycin |
Azithromycin |
3件: D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
299 1件: 299 💬 |
261 |
Po ciprofloxacin |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
262 |
Pol6014 |
- |
- |
- |
- |
299 1件: 299 💬 |
263 |
Pol7080 |
- |
- |
- |
- |
299 1件: 299 💬 |
264 |
Polaprezinc |
Polaprezinc |
1件: D01611 D01611 💬 |
- |
- |
096 2件: 96, 97 💬 |
265 |
Polidocanol |
Polidocanol |
1件: D01993 D01993 💬 |
- |
- |
279 1件: 279 💬 |
266 |
Poly iclc |
- |
- |
- |
- |
034 1件: 34 💬 |
267 |
Poly(oxy-1,2-ethanediyl), a |
- |
- |
- |
- |
235 1件: 235 💬 |
268 |
Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with n-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-teriparatide (2:1) |
Diethyl ether |
2件: D01772 D01772, D06078 D06078 💬 |
PTH1R 1件: PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
269 |
Poly-l-lactic acid |
L-Lactic acid |
1件: D00111 D00111 💬 |
- |
- |
265 1件: 265 💬 |
270 |
Polyclonal igg |
- |
- |
- |
- |
065 1件: 65 💬 |
271 |
Polydeoxyribonucleotides |
- |
- |
- |
- |
051 2件: 51, 70 💬 |
272 |
Polyethylene glycol |
Polyethylene glycol |
1件: D03370 D03370 💬 |
- |
- |
096 5件: 96, 97, 235, 276, 299 💬 |
273 |
Polyethylene glycol 3350 |
Polyethylene glycol |
1件: D03370 D03370 💬 |
- |
- |
096 2件: 96, 299 💬 |
274 |
Polymva |
- |
- |
- |
- |
002 1件: 2 💬 |
275 |
Polyphenon e |
- |
- |
- |
- |
013 2件: 13, 36 💬 |
276 |
Polyphenon e® |
- |
- |
- |
- |
097 1件: 97 💬 |
277 |
Pomalidomida |
Pomalidomide |
1件: D08976 D08976 💬 |
IL6 2件: IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
051 1件: 51 💬 |
278 |
Pomalidomide |
Pomalidomide |
1件: D08976 D08976 💬 |
IL6 2件: IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 6件: 28, 34, 51, 85, 227, 331 💬 |
279 |
Pomalidomide (cc-4047 |
Pomalidomide |
1件: D08976 D08976 💬 |
IL6 2件: IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 1件: 85 💬 |
280 |
Pomalidomide (cc-4047) |
Pomalidomide |
1件: D08976 D08976 💬 |
IL6 2件: IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
051 1件: 51 💬 |
281 |
Pomalidomide and dexamethasone |
Dexamethasone |
10件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D08976 D08976 💬 |
IL6 3件: IL6, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 79件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 1件: 28 💬 |
282 |
Pomalidomide oral product |
Pomalidomide |
1件: D08976 D08976 💬 |
IL6 2件: IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
227 1件: 227 💬 |
283 |
Pomegranate |
Pomegranate |
- |
- |
- |
096 2件: 96, 97 💬 |
284 |
Ponesimod |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
285 |
Ponesimod 10 mg |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
286 |
Ponesimod 20 mg |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
287 |
Ponesimod 40 mg |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
288 |
Ponticelli regimen |
- |
- |
- |
- |
222 1件: 222 💬 |
289 |
Pooled mesenchymal stem cell |
- |
- |
- |
- |
049 1件: 49 💬 |
290 |
Pooled plasma (human), solvent/detergent treated |
- |
- |
- |
- |
064 1件: 64 💬 |
291 |
Porcine (pig) pert |
- |
- |
- |
- |
299 1件: 299 💬 |
292 |
Porcine pert |
- |
- |
- |
- |
299 1件: 299 💬 |
293 |
Porphobilinogen |
Porphobilinogen |
- |
- |
- |
254 1件: 254 💬 |
294 |
Posaconazole |
Posaconazole |
1件: D02555 D02555 💬 |
- |
- |
060 3件: 60, 65, 299 💬 |
295 |
Posaconazole (psz) |
Posaconazole |
1件: D02555 D02555 💬 |
- |
- |
065 1件: 65 💬 |
296 |
Posaconazolo |
- |
- |
- |
- |
299 1件: 299 💬 |
297 |
Posiphen |
Posiphen |
- |
- |
- |
006 1件: 6 💬 |
298 |
Positron emission tomography using [11 carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11c]-dasb) and [18 fluorine]-altanserin ([18f]-altanserin) |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
006 1件: 6 💬 |
299 |
Positron emission tomography using [18 fluorine]-altanserin ([18f]-altanserin) |
- |
- |
- |
- |
006 1件: 6 💬 |
300 |
Postoperative 3-month exclusive enteral nutrition |
- |
- |
- |
- |
096 1件: 96 💬 |
301 |
Potassium |
Potassium |
1件: D08403 D08403 💬 |
- |
- |
036 10件: 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬 |
302 |
Potassium sparing diuretic |
Potassium |
1件: D08403 D08403 💬 |
- |
- |
235 1件: 235 💬 |
303 |
Potassium supplement |
Potassium |
1件: D08403 D08403 💬 |
- |
- |
046 1件: 46 💬 |
304 |
Potiga |
- |
- |
- |
- |
144 1件: 144 💬 |
305 |
Powder for oral suspension) |
- |
- |
- |
- |
113 1件: 113 💬 |
306 |
Prednison 5, 20 léciva por. tablet nob |
- |
- |
- |
- |
050 1件: 50 💬 |
307 |
Prednison 5, 20 léciva por. tablet nob. |
- |
- |
- |
- |
050 1件: 50 💬 |
308 |
Privigen 100 mg/ml, solution pour perfusion |
- |
- |
- |
- |
053 1件: 53 💬 |
309 |
Procedure: blood collection for pk testing (15 minutes post injection) |
- |
- |
- |
- |
046 1件: 46 💬 |
310 |
Procedure: blood collection for pk testing (18-20 hours post injection) |
- |
- |
- |
- |
046 1件: 46 💬 |
311 |
Procedure: blood collection for pk testing (180 minutes post injection) |
- |
- |
- |
- |
046 1件: 46 💬 |
312 |
Procedure: blood collection for pk testing (60 minutes post injection) |
- |
- |
- |
- |
046 1件: 46 💬 |
313 |
Procedure: injections on posterior bladder wall excluding the trigone |
- |
- |
- |
- |
226 1件: 226 💬 |
314 |
Procedure: positron emission tomography |
- |
- |
- |
- |
040 4件: 40, 46, 49, 96 💬 |
315 |
Procedure: posterior ra |
- |
- |
- |
- |
075 1件: 75 💬 |
316 |
Procedure: posterolateral spinal fusion with instrumentation |
- |
- |
- |
- |
070 1件: 70 💬 |
317 |
Procedure: power doppler ultrasonography |
- |
- |
- |
- |
046 1件: 46 💬 |
318 |
Procedure: spect imaging (180 minutes post-injection) |
- |
- |
- |
- |
046 1件: 46 💬 |
319 |
Procedure: spect imaging (60 minutes post-injection) |
- |
- |
- |
- |
046 1件: 46 💬 |
320 |
Procedure: status post lung transplant |
- |
- |
- |
- |
228 1件: 228 💬 |
321 |
Procedure: whole body planar spect imaging (15 minutes post-injection) |
- |
- |
- |
- |
046 1件: 46 💬 |
322 |
Procedure: whole body planar spect imaging (18-20 hours post-injection) |
- |
- |
- |
- |
046 1件: 46 💬 |
323 |
Procedure: whole body planar spect imaging (180 minutes post-injection) |
- |
- |
- |
- |
046 1件: 46 💬 |
324 |
Procedure: whole body planar spect imaging (60 minutes post-injection) |
- |
- |
- |
- |
046 1件: 46 💬 |
325 |
Promixin 1 million international units (iu) powder for nebuliser solution |
- |
- |
- |
- |
299 1件: 299 💬 |
326 |
Promixin, 1 million international units (iu) powder for nebuliser solution |
- |
- |
- |
- |
299 1件: 299 💬 |
327 |
Promixin,1 millón de unidades internacionales,polvo para solución para inhalación por nebulizador |
- |
- |
- |
- |
299 1件: 299 💬 |
328 |
Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis a, hepatitis b, tick-borne encephalitis, meningococcal, pneumococcal) |
- |
- |
- |
- |
013 1件: 13 💬 |
329 |
Pseudoephedrine |
Pseudoephedrine |
4件: D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 1件: 17 💬 |
330 |
Pseudoephedrine + 480 ml water |
Pseudoephedrine |
5件: D00001 D00001, D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 1件: 17 💬 |
331 |
Pseudoephedrine + 50 ml water |
Pseudoephedrine |
5件: D00001 D00001, D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 1件: 17 💬 |
332 |
Psyllium husk powder |
Plantago seed |
1件: D05525 D05525 💬 |
- |
- |
097 1件: 97 💬 |
333 |
Quinidine |
Quinidine |
4件: D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
002 3件: 2 , 8 , 13 💬 |
334 |
Quinidine sulfate |
Quinidine |
4件: D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 1件: 13 💬 |
335 |
Radiation: pet (positron emission tomography) study |
- |
- |
- |
- |
017 1件: 17 💬 |
336 |
Radiolabelled oligog cf-5/20 dry powder for inhalation (dpi) |
- |
- |
- |
- |
299 1件: 299 💬 |
337 |
Raptiva 100 mg/ml powder and solvent for solution for injection |
- |
- |
- |
- |
011 7件: 11, 13, 46, 53, 61, 95, 96 💬 |
338 |
Recombinant human porphobilinogen deaminase (porphozym) |
Porphobilinogen |
- |
- |
- |
254 1件: 254 💬 |
339 |
Recombinant porcine coagulation factor viii (b domain deleted) |
Beroctocog alfa |
- |
- |
- |
288 1件: 288 💬 |
340 |
Recombinant porcine coagulation factor viii (b-domain deleted) |
Beroctocog alfa |
- |
- |
- |
288 1件: 288 💬 |
341 |
Remicade 100 mg polvo para concentrado para solución para perfusión |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
342 |
Remicade 100 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
343 |
Remsima - 100 mg polvere per concentrato per soluzione per infusione - uso endovenoso - flanconcino (vetro) - 1 flaconcino |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
344 |
Retigabine/ezogabine |
Ezogabine |
1件: D09569 D09569 💬 |
KCNQ1 5件: KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 |
Adrenergic signaling in cardiomyocytes 6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection |
144 1件: 144 💬 |
345 |
Revatio 10 mg/ml powder for oral suspension |
- |
- |
- |
- |
086 1件: 86 💬 |
346 |
Revatio pos |
- |
- |
- |
- |
086 1件: 86 💬 |
347 |
Rt234 - vardenafil inhalation powder |
Vardenafil |
3件: D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
348 |
S-warfarin |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
013 1件: 13 💬 |
349 |
Saizen 8mg click.easy powder for solution for injection |
- |
- |
- |
- |
078 1件: 78 💬 |
350 |
Saizen 8mg click.easy power for solution for injection |
- |
- |
- |
- |
078 1件: 78 💬 |
351 |
Sandostatina - lar 20 mg/2.5 ml polvere e solvente per sospensione iniettabile flacone polvere + siringa preriempita 2.5 ml + 2 aghi |
- |
- |
- |
- |
067 1件: 67 💬 |
352 |
Sildenafil and losartan |
Losartan |
4件: D00357 D00357, D02229 D02229, D08146 D08146, D08514 D08514 💬 |
AGTR1 2件: AGTR1, PDE5A 💬 |
AGE-RAGE signaling pathway in diabetic complications 18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
085 1件: 85 💬 |
353 |
Sinvastatina sandoz 40 mg comprimidos revestidos por película |
- |
- |
- |
- |
013 1件: 13 💬 |
354 |
Sirolimus and hydroxychloroquine 200 mg |
Hydroxychloroquine |
2件: D00753 D00753, D08050 D08050 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
089 1件: 89 💬 |
355 |
Sirolimus and hydroxychloroquine 400 mg |
Hydroxychloroquine |
2件: D00753 D00753, D08050 D08050 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
089 1件: 89 💬 |
356 |
Solu medrol - 125 mg/2 ml polvere e solvente per soluzione iniettabile 1 flacone a doppia camera da 125 mg/2 ml |
- |
- |
- |
- |
013 3件: 13, 14, 53 💬 |
357 |
Solu-cortef, powder for solution for injection, 100mg, and 'act-o-vial' |
- |
- |
- |
- |
006 1件: 6 💬 |
358 |
Spd476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
359 |
Sulphasalazine + hydroxychloroquine or prednisolone |
Hydroxychloroquine |
9件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D08050 D08050 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
046 1件: 46 💬 |
360 |
Sweet polvilho |
- |
- |
- |
- |
257 1件: 257 💬 |
361 |
Synthetic 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker |
- |
- |
- |
- |
062 1件: 62 💬 |
362 |
Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication) |
Amoxicillin |
7件: D00229 D00229, D00276 D00276, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
063 1件: 63 💬 |
363 |
Tedizolid po |
Tedizolid |
1件: D09685 D09685 💬 |
- |
- |
299 1件: 299 💬 |
364 |
Teicoplanin sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. |
Teicoplanin |
1件: D02142 D02142 💬 |
- |
- |
299 1件: 299 💬 |
365 |
Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker |
Polyethylene glycol |
2件: D03370 D03370, D06078 D06078 💬 |
PTH1R 1件: PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
366 |
The generic name is warfarin and many producers will be involved |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
049 1件: 49 💬 |
367 |
The investigational medicinal product (imp) may be labelled as either pf-04236921 106 mg/vial, clonal sc lyophilized form” or pf-04236921 powder for injection, 106 mg/vial”. supplies labelled with either nomenclature are equivalent. |
- |
- |
- |
- |
096 1件: 96 💬 |
368 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta |
- |
- |
- |
- |
096 1件: 96 💬 |
369 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta. |
- |
- |
- |
- |
096 1件: 96 💬 |
370 |
The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 1件: 86 💬 |
371 |
The pops study is collecting pk data on children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 1件: 86 💬 |
372 |
Tip (tobramycin inhalation powder) |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
373 |
Tis (tobramycin inhalation solution) |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
374 |
Tobi (tobramycin) |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
375 |
Tobi 300 mg/5 ml solución para inhalación por nebulizador |
- |
- |
- |
- |
299 1件: 299 💬 |
376 |
Tobi 300 mg/5 ml, solution pour inhalation par nébuliseur |
- |
- |
- |
- |
299 1件: 299 💬 |
377 |
Tobi 300mg/5ml solución para inhalación por nebulizador. |
- |
- |
- |
- |
299 1件: 299 💬 |
378 |
Tobi podhaler |
- |
- |
- |
- |
299 1件: 299 💬 |
379 |
Tobi podhaler - 28 mg polvere per inalazione capsula rigida uso inalatorio blister(alu/alu) 56 capsule + 1 inalatore |
- |
- |
- |
- |
299 1件: 299 💬 |
380 |
Tobi podhaler 28 mg hartkapseln mit pulver zur inhalation |
- |
- |
- |
- |
299 1件: 299 💬 |
381 |
Tobi podhaler 28 mg inhalációs por, kemény kapszula |
- |
- |
- |
- |
299 1件: 299 💬 |
382 |
Tobi podhaler*448cps 28mg+10in |
- |
- |
- |
- |
299 1件: 299 💬 |
383 |
Tobi™ podhaler™ 112 mg inhaled twice daily |
- |
- |
- |
- |
299 1件: 299 💬 |
384 |
Tobramicina polvere inalatoria |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
385 |
Tobramycin |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
386 |
Tobramycin (gernebcin®) |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
387 |
Tobramycin / bramitob |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
388 |
Tobramycin / tobi |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
389 |
Tobramycin 100 pari |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
390 |
Tobramycin dry powder |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
391 |
Tobramycin for inhalation |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
392 |
Tobramycin inhalation powder |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
393 |
Tobramycin inhalation powder (tip) |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
394 |
Tobramycin inhalation powder tip delivered by the t-326 inhaler |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
395 |
Tobramycin inhalation solution |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
396 |
Tobramycin inhalation solution (tis) |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
397 |
Tobramycin inhalation solution using a pari lc® plus nebulizer. |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
398 |
Tobramycin injection 40mg/1ml |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
399 |
Tobramycin nebulized nasally |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
400 |
Tobramycin powder |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
401 |
Tobramycin solution for inhalation |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
402 |
Tobramycin solution for inhalation (tobi) |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
403 |
Tobramycin solution for inhalation 300 mg |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
404 |
Tobramycin steri-neb 300 mg/5 ml, inhalation solution |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
405 |
Tobramycin sulfate |
Sulfate ion |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
406 |
Tofacitinib 5mg po bid |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 1件: 46 💬 |
407 |
Topotecan |
Topotecan |
2件: D02168 D02168, D08618 D08618 💬 |
- |
- |
025 1件: 25 💬 |
408 |
Transdermal nicotine |
Nicotine |
3件: D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 1件: 6 💬 |
409 |
Treatment with polyethylene glycol (macrogol 4000) |
Polyethylene glycol |
1件: D03370 D03370 💬 |
- |
- |
299 1件: 299 💬 |
410 |
Treprostinil inhalation powder |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 1件: 86 💬 |
411 |
Tripterygium wilfordii polyglycosidium |
Tripterygium wilfordii whole |
- |
- |
- |
224 1件: 224 💬 |
412 |
Tysabri 300 mg solution à diluer pour perfusion |
- |
- |
- |
- |
013 1件: 13 💬 |
413 |
Vancomycin hydrochloride inhalation powder |
Vancomycin |
2件: D00212 D00212, D00926 D00926 💬 |
- |
- |
299 1件: 299 💬 |
414 |
Vancomycin inhalation powder |
Vancomycin |
2件: D00212 D00212, D00926 D00926 💬 |
- |
- |
299 1件: 299 💬 |
415 |
Vantobra (tobramycin) |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
416 |
Versus hydroxychloroquine |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
049 1件: 49 💬 |
417 |
Veyondi 650iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 1件: 288 💬 |
418 |
Veyvondi 1300iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 1件: 288 💬 |
419 |
Veyvondi 650iu powder and solvent for solution for injection |
- |
- |
- |
- |
288 1件: 288 💬 |
420 |
Vfend 40 mg/ml powder for oral suspension |
- |
- |
- |
- |
299 1件: 299 💬 |
421 |
Vitamin d powder |
Vitamin D |
- |
- |
- |
299 1件: 299 💬 |
422 |
Vpriv - 400 u - polvere per soluzione per infusione - uso endovenoso - flaconcino(vetro) 1 flaconcino |
- |
- |
- |
- |
019 1件: 19 💬 |
423 |
Vpriv 400 units powder for solution of infusion |
- |
- |
- |
- |
019 1件: 19 💬 |
424 |
Warfarin |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
425 |
Warfarin 10 mg |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
096 2件: 96, 97 💬 |
426 |
Warfarin sodium |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
049 1件: 49 💬 |
427 |
Warfarin+ vitamin k |
Phylloquinone |
4件: D00148 D00148, D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
046 1件: 46 💬 |
428 |
Wuling powder |
- |
- |
- |
- |
006 1件: 6 💬 |
429 |
Yondelis 0,25 mg polvo para concentrado para solución para perfusión |
- |
- |
- |
- |
159 1件: 159 💬 |
430 |
Yondelis 0.25 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
159 1件: 159 💬 |
431 |
Yondelis 1 mg polvo para concentrado para solución para perfusión |
- |
- |
- |
- |
159 1件: 159 💬 |
432 |
Yondelis 1 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
159 1件: 159 💬 |
433 |
Zx008 (fenfluramine hydrochloride) |
Fenfluramine |
1件: D07945 D07945 💬 |
HTR2A 4件: HTR2A, HTR2B, HTR2C, SLC6A4 💬 |
Calcium signaling pathway 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
140 2件: 140, 144 💬 |